Sangamo Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.

About SGMO

Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases. 

CEO
Alexander D. Macrae
CEOAlexander D. Macrae
Employees
183
Employees183
Headquarters
Richmond, California
HeadquartersRichmond, California
Founded
1995
Founded1995
Employees
183
Employees183

SGMO Key Statistics

Market cap
128.44M
Market cap128.44M
Price-Earnings ratio
-1.38
Price-Earnings ratio-1.38
Dividend yield
Dividend yield
Average volume
8.46M
Average volume8.46M
High today
$0.5461
High today$0.5461
Low today
$0.5217
Low today$0.5217
Open price
$0.5354
Open price$0.5354
Volume
5.42M
Volume5.42M
52 Week high
$3.18
52 Week high$3.18
52 Week low
$0.4111
52 Week low$0.4111

Analyst ratings

67%

of 6 ratings
Buy
66.7%
Hold
33.3%
Sell
0%

People also own

Based on the portfolios of people who own SGMO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.